Acquisition agreement for SeagenAcquisition Agreement • November 17th, 2023 • Delaware
Contract Type FiledNovember 17th, 2023 JurisdictionPfizer and Seagen have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise value of